Packaged drug reduces mother-to-infant HIV infection
May 17th, 2010 - 4:02 pm ICT by IANSWashington, May 17 (IANS) By using medications packaged just like fast-food ketchup, HIV-positive mothers in developing countries can more easily provide protection to newborn babies born at home.
Biomedical engineers at Duke University have developed a cheap, easy-to-use system that allows mothers to give their newborns a potentially life-saving dose of an anti-HIV medication shortly after birth.
In order to be effective, the drug, known as Nevirapine, must be given to the newborn within days of birth. The challenge to date has been reaching distant mothers who give birth at home.
Since most mothers are not up to travelling that soon after delivery to get medication, biomedical engineers developed a way of providing the medication in a simple manner and with a long shelf life — pouches made of foil and plastic that can hold a single dose of Nevirapine.
“In Africa, the World Health Organisation (WHO) estimates that more than 90 percent of 430,000 new cases of AIDS in 2008 were attributable to mother-to-child transmission,” said Carolina Gamache, programme coordinator in senior researcher Robert Malkin’s Developing World Healthcare Technology Laboratory at Duke’s Pratt School of Engineering.
“A single dose of Nevirapine right after birth has been shown to be effective in protecting the baby from the virus, but it has been difficult for many reasons to make this option available to women who give birth at home,” said Gamache, according to a Duke release.
Gamache presented the results of the Duke research in London at the Appropriate Healthcare Technologies for Developing Countries conference, which is sponsored by the WHO and the Institute of Engineering and Technology.
- New, inexpensive pouch could reduce mother-to-infant HIV infection - May 14, 2010
- HIV drug given to protect foetus should be avoided after childbirth for 1yr - Feb 26, 2010
- Mother-to-child HIV transmission on decline in US, but more can be done - Jul 23, 2010
- 6-month drug regimen 'reduces HIV risk for breastfeeding infants' - Mar 03, 2011
- Vitamin A makes breastfeeding with HIV more risky: Study - Aug 27, 2010
- New HIV/AIDS study could turn treatment 'on its head' - Mar 04, 2011
- Pregnant women living near highways likelier to give birth prematurely - Apr 04, 2011
- Pregnancy stress can affect baby's iron status: Study - Apr 30, 2012
- New research could 'protect newborn babies from HIV infection' - Oct 04, 2010
- Mother's touch vital for newborn's well being - Nov 03, 2011
- Home births could put babies at risk, say docs - Jul 30, 2010
- Traces of HIV drug in mother's milk risks newborn - Aug 06, 2008
- Daily antiretroviral therapy may prevent mother-to-child HIV transmission - Jul 23, 2009
- Why HIV-uninfected babies of mums with HIV are more prone to infections - Feb 09, 2011
- HAART may help reduce mother-to-child HIV transmission - Aug 02, 2009
Tags: biomedical engineers, birth at home, child transmission, days of birth, developing world, duke research, duke university, gamache, healthcare technologies, healthcare technology, hiv infection, hiv medication, nevirapine, newborn babies, newborns, pratt school, robert malkin, technology laboratory, world health organisation, world healthcare